|
Q1 FY2027
As of Jul 31, 2026
|
Q4 FY2026
As of Apr 24, 2026
|
Q3 FY2026
As of Jan 23, 2026
|
Q2 FY2026
As of Oct 24, 2025
|
Q1 FY2026
As of Jul 25, 2025
|
Q4 FY2025
As of Apr 25, 2025
|
Q3 FY2025
As of Jan 24, 2025
|
Q2 FY2025
As of Oct 25, 2024
|
Q1 FY2025
As of Jul 26, 2024
|
Q4 FY2024
As of Apr 26, 2024
|
Q3 FY2024
As of Jan 26, 2024
|
Q2 FY2024
As of Oct 27, 2023
|
Q1 FY2024
As of Jul 28, 2023
|
Q4 FY2023
As of Apr 28, 2023
|
Q3 FY2023
As of Jan 27, 2023
|
Q2 FY2023
As of Oct 28, 2022
|
Q1 FY2023
As of Jul 29, 2022
|
Q4 FY2022
As of Apr 29, 2022
|
Q3 FY2022
As of Jan 28, 2022
|
Q2 FY2022
As of Oct 29, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Accounts receivable, less allowances for credit losses of $203 and $190, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Tax assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Current debt obligations | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Accrued income taxes | ||||||||||||||||||||
| Other accrued expenses | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Accrued compensation and retirement benefits | ||||||||||||||||||||
| Accrued income taxes | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Ordinary shares— par value $0.0001, 2.6 billion shares authorized, 1,280,046,863 and 1,280,177,293 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
